Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

57 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[No title available]
[No authors listed] [No authors listed] PMID: 33004256
Epidemiology and outcome of HIV-infected patients admitted to the ICU in the current highly active antiretroviral therapy era.
Vidal-Cortés P, Álvarez-Rocha LA, Fernández-Ugidos P, Pérez-Veloso MA, Suárez-Paul IM, Virgós-Pedreira A, Pértega-Díaz S, Castro-Iglesias ÁC. Vidal-Cortés P, et al. Med Intensiva (Engl Ed). 2020 Jun-Jul;44(5):283-293. doi: 10.1016/j.medin.2019.02.012. Epub 2019 Apr 7. Med Intensiva (Engl Ed). 2020. PMID: 30971339 English, Spanish.
Short article: Viral dynamics among hepatitis C virus chronic infected patients during direct-acting antiviral agents therapy: impact for monitoring and optimizing treatment duration.
Tabernilla A, Grandal M, Pernas B, Castro-Iglesias A, Rodríguez-Osorio I, Mena A, Delgado M, Cid P, Pedreira JD, Poveda E. Tabernilla A, et al. Eur J Gastroenterol Hepatol. 2017 Jul;29(7):781-785. doi: 10.1097/MEG.0000000000000882. Eur J Gastroenterol Hepatol. 2017. PMID: 28410351
Clinical Experience with the Integrase Inhibitors Dolutegravir and Elvitegravir in HIV-infected Patients: Efficacy, Safety and Tolerance.
Cid-Silva P, Llibre JM, Fernández-Bargiela N, Margusino-Framiñán L, Balboa-Barreiro V, Pernas-Souto B, Martín-Herranz I, Castro-Iglesias Á, Poveda E. Cid-Silva P, et al. Basic Clin Pharmacol Toxicol. 2017 Nov;121(5):442-446. doi: 10.1111/bcpt.12828. Epub 2017 Jul 16. Basic Clin Pharmacol Toxicol. 2017. PMID: 28627771 Free article.
Treatment with tenofovir alafenamide fumarate worsens the lipid profile of HIV-infected patients versus treatment with tenofovir disoproxil fumarate, each coformulated with elvitegravir, cobicistat, and emtricitabine.
Cid-Silva P, Fernández-Bargiela N, Margusino-Framiñán L, Balboa-Barreiro V, Mena-De-Cea Á, López-Calvo S, Vázquez-Rodríguez P, Martín-Herranz I, Míguez-Rey E, Poveda E, Castro-Iglesias Á. Cid-Silva P, et al. Basic Clin Pharmacol Toxicol. 2019 Apr;124(4):479-490. doi: 10.1111/bcpt.13161. Epub 2018 Dec 7. Basic Clin Pharmacol Toxicol. 2019. PMID: 30388308 Free article.
57 results